Overview
Intuitive Surgical, Inc., based in the United States, is a prominent pioneer in the field of robotic-assisted, minimally invasive surgery. Central to its portfolio is the renowned da Vinci Surgical System, which enhances surgical precision and dexterity while minimizing patient recovery times. Beyond its flagship technology, the company invests heavily in research and development to refine its existing systems and innovate new solutions that address complex surgical challenges. Key projects focus on expanding the applicability of robotics across a broader range of surgical procedures and enhancing the integration of advanced imaging and data analytics to improve surgical outcomes. These efforts underscore Intuitive Surgical's commitment to advancing the field of surgical robotics and expanding its market presence globally.
Basic Stats
The share price of Intuitive Surgical, Inc. as of September 5, 2025 is $466.95 / share. This is a decrease of -1.34% from the prior week. The market cap (or net worth) of Intuitive Surgical, Inc. as of September 5, 2025 is $167,401.58 MM.
The Factor Analysis chart (below right) shows a view of Intuitive Surgical, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 167,401.58 MM |
| EV | 157,976.48 MM |
| Shares Out. | 358.50 MM |
| Earnings Date | |
| EPS (TTM) | 7.27 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.25 |
| Short Shares Avail. | 3.90 MM |
| Short Interest | 4.98 MM |
| Short Float | 1.40 % |
| Days to Cover | 1.75 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -2.04 % |
| Volatility (1 yr) | 0.33 |
| Beta | 1.10 |
| Sharpe Ratio (1 yr) | -0.19 |
| Sortino Ratio (1 yr) | -0.31 |
| PE Ratio | 64.20 |
| Price/Book | 9.32 |
| Price/TBV | 9.51 |
| Book/Market | 0.11 |
| EBIT/EV | 0.02 |
| EBIT(3yr avg)/EV | 0.01 |
| ROA | 0.16 |
| ROE | 0.18 |
| ROIC | 0.15 |
| CROIC | 0.02 |
| OCROIC | 0.16 |
| Implied Volatility | 27.98 % |
| Put/Call OI Ratio | 0.97 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Intuitive Surgical, Inc. is $597.45. The forecasts range from a low of $444.40 to a high of $719.25. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Intuitive Surgical, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-12-22 | Argus Research | Buy | Maintains | |
| 2022-12-20 | Truist Securities | Buy | Maintains | |
| 2022-12-12 | Wells Fargo | Overweight | Maintains | |
| 2022-12-05 | BTIG | Buy | Maintains | |
| 2022-11-18 | JP Morgan | Overweight | Maintains | |
| 2022-10-20 | Deutsche Bank | Hold | Maintains | |
| 2022-10-19 | Wells Fargo | Overweight | Maintains | |
| 2022-10-19 | Truist Securities | Buy | Maintains | |
| 2022-10-19 | Piper Sandler | Overweight | Maintains | |
| 2022-10-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-18 | Barclays | Overweight | Initiate | |
| 2022-10-17 | Truist Securities | Buy | Maintains | |
| 2022-10-13 | Mizuho | Neutral | Initiate | |
| 2022-10-12 | Jefferies | Hold | Initiate | |
| 2022-10-11 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-09-09 | Stifel | Buy | Maintains | |
| 2022-08-18 | Piper Sandler | Overweight | Maintains | |
| 2022-07-22 | Truist Securities | Buy | Maintains | |
| 2022-07-22 | RBC Capital | Outperform | Maintains | |
| 2022-07-22 | Raymond James | Outperform | Maintains | |
| 2022-07-22 | Piper Sandler | Overweight | Maintains | |
| 2022-07-22 | Deutsche Bank | Hold | Maintains | |
| 2022-07-22 | Citigroup | Buy | Maintains | |
| 2022-07-18 | Stifel | Buy | Maintains | |
| 2022-07-18 | BTIG | Buy | Maintains | |
| 2022-07-15 | Raymond James | Outperform | Maintains | |
| 2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-13 | Truist Securities | Buy | Maintains | |
| 2022-06-22 | Deutsche Bank | Hold | Maintains | |
| 2022-05-17 | Citigroup | Buy | Maintains | |
| 2022-04-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-04-22 | Wells Fargo | Overweight | Maintains | |
| 2022-04-22 | Raymond James | Outperform | Maintains | |
| 2022-04-22 | Piper Sandler | Overweight | Maintains | |
| 2022-04-13 | Truist Securities | Buy | Initiate | |
| 2022-04-06 | Wolfe Research | Peer Perform | Initiate | |
| 2022-03-25 | RBC Capital | Outperform | Initiate | |
| 2022-02-02 | UBS | Neutral | Buy | Upgrade |
| 2022-01-31 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2022-01-25 | Redburn Partners | Buy | Neutral | Downgrade |
| 2022-01-21 | Wells Fargo | Overweight | Maintains | |
| 2022-01-21 | Raymond James | Outperform | Maintains | |
| 2022-01-21 | Piper Sandler | Neutral | Maintains | |
| 2022-01-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-01-21 | Deutsche Bank | Hold | Maintains | |
| 2022-01-21 | Citigroup | Neutral | Buy | Upgrade |
| 2022-01-10 | BTIG | Neutral | Buy | Upgrade |
| 2022-01-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-20 | Wells Fargo | Overweight | Maintains | |
| 2021-10-05 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-10-01 | Citigroup | Buy | Neutral | Downgrade |
| 2021-08-26 | SVB Leerink | Market Perform | Maintains | |
| 2021-07-22 | Deutsche Bank | Hold | Maintains | |
| 2021-07-21 | Wells Fargo | Overweight | Maintains | |
| 2021-07-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-07-21 | Evercore ISI Group | In-Line | Maintains | |
| 2021-07-21 | Citigroup | Buy | Maintains | |
| 2021-07-20 | SVB Leerink | Market Perform | Maintains | |
| 2021-07-14 | Stifel | Buy | Maintains | |
| 2021-06-07 | Wells Fargo | Overweight | Maintains | |
| 2021-06-01 | Evercore ISI Group | Underperform | In-Line | Upgrade |
| 2021-05-24 | Argus Research | Buy | Maintains | |
| 2021-04-21 | SVB Leerink | Market Perform | Maintains | |
| 2021-04-21 | Piper Sandler | Neutral | Maintains | |
| 2021-04-21 | Oppenheimer | Underperform | Perform | Upgrade |
| 2021-04-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-04-21 | Deutsche Bank | Hold | Maintains | |
| 2021-04-21 | Citigroup | Buy | Maintains | |
| 2021-04-21 | Baird | Neutral | Outperform | Upgrade |
| 2021-04-01 | Citigroup | Buy | Initiate | |
| 2021-03-31 | Piper Sandler | Neutral | Maintains | |
| 2021-01-22 | Raymond James | Outperform | Maintains | |
| 2020-12-15 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2020-10-16 | Wells Fargo | Overweight | Maintains | |
| 2020-10-16 | SVB Leerink | Market Perform | Maintains | |
| 2020-10-16 | Morgan Stanley | Overweight | Maintains | |
| 2020-10-12 | Raymond James | Outperform | Maintains | |
| 2020-09-28 | Argus Research | Buy | Initiate | |
| 2020-09-11 | Wolfe Research | Outperform | Initiate | |
| 2020-09-08 | B of A Securities | Buy | Neutral | Downgrade |
| 2020-09-02 | Baird | Neutral | Initiate | |
| 2020-08-14 | SVB Leerink | Market Perform | Maintains | |
| 2020-07-22 | Wells Fargo | Overweight | Maintains | |
| 2020-07-22 | UBS | Neutral | Maintains | |
| 2020-07-22 | SVB Leerink | Market Perform | Maintains | |
| 2020-07-22 | Stifel | Buy | Maintains | |
| 2020-07-22 | Raymond James | Outperform | Maintains | |
| 2020-07-22 | Morgan Stanley | Overweight | Maintains | |
| 2020-07-22 | Deutsche Bank | Hold | Maintains | |
| 2020-07-22 | Canaccord Genuity | Buy | Maintains | |
| 2020-07-15 | SVB Leerink | Market Perform | Maintains | |
| 2020-06-18 | JP Morgan | Overweight | Maintains | |
| 2020-06-04 | Wells Fargo | Overweight | Maintains | |
| 2020-04-28 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2020-04-17 | Wells Fargo | Overweight | Maintains | |
| 2020-04-17 | UBS | Neutral | Maintains | |
| 2020-04-17 | SVB Leerink | Outperform | Market Perform | Downgrade |
| 2020-04-17 | Deutsche Bank | Hold | Maintains | |
| 2020-04-17 | Canaccord Genuity | Buy | Maintains | |
| 2020-04-13 | Raymond James | Outperform | Maintains | |
| 2020-04-09 | Evercore ISI Group | In-Line | Underperform | Downgrade |
| 2020-04-02 | Wells Fargo | Overweight | Maintains | |
| 2020-04-01 | Oppenheimer | Perform | Underperform | Downgrade |
| 2020-03-27 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-24 | Stifel | Buy | Maintains | |
| 2020-03-17 | JP Morgan | Overweight | Maintains | |
| 2020-02-13 | Goldman Sachs | Buy | Initiate | |
| 2020-01-27 | Deutsche Bank | Buy | Hold | Downgrade |
| 2020-01-24 | Raymond James | Outperform | Maintains | |
| 2020-01-24 | JP Morgan | Overweight | Maintains | |
| 2020-01-10 | UBS | Neutral | Maintains | |
| 2020-01-10 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2019-12-17 | Morgan Stanley | Overweight | Maintains | |
| 2019-11-29 | First Shanghai | Buy | Initiate | |
| 2019-11-21 | Oppenheimer | Perform | Initiate | |
| 2019-10-18 | UBS | Neutral | Maintains | |
| 2019-07-19 | Canaccord Genuity | Buy | Maintains | |
| 2019-05-14 | Citigroup | Buy | Maintains | |
| 2019-04-23 | Citigroup | Buy | Buy | Maintains |
| 2019-04-22 | Raymond James | Outperform | Outperform | Maintains |
| 2019-04-22 | Canaccord Genuity | Buy | Buy | Maintains |
| 2019-04-02 | Deutsche Bank | Buy | Initiate | |
| 2019-04-01 | Raymond James | Outperform | Outperform | Maintains |
| 2019-01-02 | Citigroup | Buy | Buy | Maintains |
| 2018-11-29 | Citigroup | Buy | Buy | Maintains |
| 2018-11-28 | UBS | Neutral | Initiate | |
| 2018-10-19 | Raymond James | Outperform | Outperform | Maintains |
| 2018-10-19 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2018-10-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-10-10 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2018-10-09 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2018-09-12 | Wells Fargo | Outperform | Outperform | Maintains |
| 2018-08-02 | Citigroup | Buy | Buy | Maintains |
| 2018-07-20 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-07-20 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-07-17 | Bank of America | Buy | Buy | Maintains |
| 2018-06-27 | Bernstein | Outperform | Initiate | |
| 2018-06-01 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-18 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-04-18 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-18 | Canaccord Genuity | Hold | Hold | Maintains |
| 2018-04-18 | Bank of America | Buy | Buy | Maintains |
| 2018-02-06 | Citigroup | Buy | Buy | Maintains |
| 2018-01-26 | Stifel Nicolaus | Buy | Buy | Maintains |
| 2018-01-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-01-26 | Canaccord Genuity | Hold | Hold | Maintains |
| 2018-01-26 | Barclays | Overweight | Overweight | Maintains |
| 2018-01-03 | Evercore ISI Group | In-Line | Initiate | |
| 2017-10-23 | Citigroup | Buy | Maintains | |
| 2017-10-20 | Morgan Stanley | Overweight | Maintains | |
| 2017-10-20 | Barclays | Overweight | Maintains | |
| 2017-07-25 | Morgan Stanley | Overweight | Maintains | |
| 2017-06-30 | Cantor Fitzgerald | Neutral | Initiate | |
| 2017-05-16 | Goldman Sachs | Buy | Initiate | |
| 2017-01-04 | Evercore ISI Group | Buy | Hold | Downgrade |
| 2016-10-13 | Wells Fargo | Outperform | Initiate | |
| 2016-08-26 | Raymond James | Outperform | Initiate | |
| 2016-07-20 | Citigroup | Buy | Maintains | |
| 2016-07-20 | Barclays | Overweight | Maintains | |
| 2016-06-02 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2016-04-20 | Bank of America | Buy | Maintains | |
| 2016-04-01 | BTIG Research | Buy | Neutral | Downgrade |
| 2016-01-04 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2015-11-12 | Citigroup | Buy | Initiate | |
| 2015-07-22 | Canaccord Genuity | Buy | Upgrade | |
| 2015-07-22 | Barclays | Overweight | Maintains | |
| 2015-07-06 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2015-06-25 | Barclays | Overweight | Initiate | |
| 2015-05-12 | PiperJaffray | Neutral | Initiate | |
| 2015-01-05 | Jefferies | Buy | Maintains | |
| 2015-01-02 | Bank of America | Buy | Maintains | |
| 2014-10-22 | Northland Securities | Underperform | Market Perform | Upgrade |
| 2014-10-22 | BTIG Research | Neutral | Buy | Upgrade |
| 2014-10-17 | Leerink Swann | Market Perform | Outperform | Upgrade |
| 2014-10-06 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2014-09-22 | RBC Capital | Sector Perform | Initiate | |
| 2014-07-23 | Stifel Nicolaus | Hold | Buy | Upgrade |
| 2014-07-23 | Raymond James | Market Perform | Outperform | Upgrade |
| 2014-07-23 | JP Morgan | Overweight | Maintains | |
| 2014-07-08 | BTIG Research | Neutral | Initiate | |
| 2014-04-29 | Sterne Agee | Underperform | Neutral | Upgrade |
| 2014-04-23 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2014-04-23 | Sterne Agee | Underperform | Maintains | |
| 2014-04-23 | Leerink Swann | Market Perform | Maintains | |
| 2014-04-23 | JP Morgan | Overweight | Maintains | |
| 2014-04-23 | Canaccord Genuity | Hold | Maintains | |
| 2014-04-14 | Leerink Swann | Market Perform | Maintains | |
| 2014-04-09 | Sterne Agee | Underperform | Initiate | |
| 2014-04-08 | Sterne Agee | Underperform | Initiate | |
| 2014-04-02 | JMP Securities | Market Underperform | Market Outperform | Upgrade |
| 2014-04-02 | Bank of America | Buy | Maintains | |
| 2014-04-01 | JP Morgan | Overweight | Maintains | |
| 2014-03-04 | Cantor Fitzgerald | Buy | Hold | Downgrade |
| 2014-01-21 | ISI Group | Strong Buy | Initiate | |
| 2013-12-05 | Jefferies | Buy | Initiate | |
| 2013-11-26 | CRT Capital | Sell | Initiate | |
| 2013-11-25 | CRT Capital | Sell | Initiate | |
| 2013-10-18 | Northland | Market Perform | Underperform | Downgrade |
| 2013-09-03 | First Analysis | Equal-Weight | Underweight | Downgrade |
| 2013-07-19 | Northland Securities | Underperform | Market Perform | Upgrade |
| 2013-07-19 | JMP Securities | Market Perform | Market Underperform | Downgrade |
| 2013-07-09 | Raymond James | Outperform | Market Perform | Downgrade |
| 2013-07-09 | JMP Securities | Market Outperform | Market Perform | Downgrade |
| 2013-07-09 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2013-07-09 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2013-07-09 | Ameriprise Financial | Buy | Sell | Downgrade |
| 2013-06-25 | First Analysis | Equal-Weight | Initiate | |
| 2013-06-18 | Wedbush | Outperform | Initiate | |
| 2013-06-17 | Wedbush | Outperform | Initiate | |
| 2013-03-18 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2013-03-05 | Northland | Underperform | Initiate | |
| 2013-03-01 | Cantor Fitzgerald | Hold | Buy | Upgrade |
| 2013-02-22 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2013-01-23 | Cantor Fitzgerald | Hold | Maintains | |
| 2013-01-18 | Janney Capital | Buy | Initiate | |
| 2013-01-17 | Janney Capital | Buy | Initiate | |
| 2013-01-16 | Goldman Sachs | Neutral | Maintains | |
| 2013-01-14 | Lazard | Neutral | Buy | Upgrade |
| 2012-12-04 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-11-20 | Stifel Nicolaus | Hold | Initiate | |
| 2012-10-31 | Barrington Research | Market Perform | Outperform | Upgrade |
| 2012-10-19 | Bank of America | Neutral | Buy | Upgrade |
| 2012-10-15 | JP Morgan | Neutral | Overweight | Upgrade |
| 2012-08-27 | Goldman Sachs | Neutral | Maintains | |
| 2012-07-25 | Mizuho | Neutral | Buy | Upgrade |
| 2012-05-30 | JP Morgan | Neutral | Maintains | |
| 2012-04-18 | JP Morgan | Neutral | Maintains | |
| 2012-04-18 | Goldman Sachs | Neutral | Maintains | |
| 2012-04-18 | Dougherty | Buy | Maintains | |
| 2012-04-18 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-04-10 | Dougherty | Buy | Initiate | |
| 2023-01-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-01-26 | Raymond James | Outperform | Maintains | |
| 2023-01-24 | Mizuho | Neutral | Maintains | |
| 2023-01-25 | Wells Fargo | Overweight | Maintains | |
| 2023-01-25 | Truist Securities | Buy | Maintains | |
| 2023-01-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-01-25 | Mizuho | Neutral | Maintains | |
| 2023-01-25 | Citigroup | Buy | Maintains | |
| 2023-01-25 | BTIG | Buy | Maintains | |
| 2023-03-23 | William Blair | Outperform | Initiate | |
| 2023-03-29 | UBS | Neutral | Initiate | |
| 2023-04-04 | Evercore ISI Group | In-Line | Maintains | |
| 2023-04-20 | Bernstein | Outperform | Maintains | |
| 2023-04-20 | Barclays | Overweight | Maintains | |
| 2023-04-19 | BTIG | Buy | Maintains | |
| 2023-04-19 | Evercore ISI Group | In-Line | Maintains | |
| 2023-04-19 | Piper Sandler | Overweight | Maintains | |
| 2023-04-19 | Deutsche Bank | Hold | Maintains | |
| 2023-04-19 | Stifel | Buy | Maintains | |
| 2023-04-17 | BTIG | Buy | Maintains | |
| 2023-04-19 | Wells Fargo | Overweight | Maintains | |
| 2023-04-19 | Mizuho | Neutral | Maintains | |
| 2023-04-19 | Citigroup | Buy | Maintains | |
| 2023-04-19 | Truist Securities | Buy | Maintains | |
| 2023-04-19 | B of A Securities | Buy | Maintains | |
| 2023-04-19 | Raymond James | Outperform | Maintains | |
| 2023-04-18 | Mizuho | Neutral | Maintains | |
| 2023-04-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-04-19 | RBC Capital | Outperform | Maintains | |
| 2023-04-19 | JP Morgan | Overweight | Maintains | |
| 2023-04-24 | RBC Capital | Outperform | Reiterate | |
| 2023-05-18 | Truist Securities | Buy | Buy | Maintains |
| 2023-05-31 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-05-31 | Bernstein | Outperform | Outperform | Maintains |
| 2023-06-05 | BTIG | Buy | Buy | Maintains |
| 2023-07-11 | Citigroup | Buy | Buy | Maintains |
| 2023-07-24 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-07-24 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-24 | Raymond James | Outperform | Outperform | Maintains |
| 2023-07-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-25 | Mizuho | Neutral | Neutral | Maintains |
| 2023-07-21 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-07-21 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-07-21 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-21 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-08-17 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-10-16 | Leerink Partners | Outperform | Initiate | |
| 2023-12-22 | Truist Securities | Buy | Buy | Maintains |
| 2023-11-17 | HSBC | Buy | Initiate | |
| 2024-03-15 | Stifel | Buy | Buy | Reiterate |
| 2023-07-19 | Truist Securities | Buy | Buy | Maintains |
| 2023-07-19 | Baird | Outperform | Outperform | Initiate |
| 2023-10-20 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-10-20 | Citigroup | Buy | Buy | Maintains |
| 2023-10-20 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-10-20 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-10-20 | Raymond James | Outperform | Outperform | Maintains |
| 2023-12-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-17 | Stifel | Buy | Buy | Maintains |
| 2023-10-23 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-12-12 | Truist Securities | Buy | Buy | Maintains |
| 2024-01-24 | Truist Securities | Buy | Buy | Maintains |
| 2024-01-24 | Stifel | Buy | Buy | Maintains |
| 2024-01-24 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-24 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-04-19 | Jefferies | Hold | Hold | Maintains |
| 2024-04-19 | BTIG | Buy | Buy | Maintains |
| 2024-04-19 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-04-19 | Baird | Outperform | Outperform | Maintains |
| 2024-01-25 | Raymond James | Outperform | Outperform | Maintains |
| 2024-01-19 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-01-12 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-04-08 | Stifel | Buy | Buy | Maintains |
| 2024-01-03 | Raymond James | Outperform | Outperform | Maintains |
| 2024-01-25 | Barclays | Overweight | Overweight | Maintains |
| 2024-05-30 | Goldman Sachs | Buy | Initiate | |
| 2024-04-03 | Citigroup | Buy | Buy | Maintains |
| 2024-07-10 | Citigroup | Buy | Buy | Maintains |
| 2024-07-02 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-07-15 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-15 | BTIG | Buy | Buy | Maintains |
| 2024-07-09 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-07-16 | Truist Securities | Buy | Buy | Maintains |
| 2025-07-23 | Truist Securities | Buy | Buy | Maintains |
| 2024-10-11 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-07-23 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2025-07-23 | UBS | Neutral | Neutral | Maintains |
| 2025-07-23 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-23 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-07-18 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-02 | Redburn Atlantic | Neutral | Buy | Upgrade |
| 2025-04-23 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-04-23 | Truist Securities | Buy | Buy | Maintains |
| 2025-04-23 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-04-23 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-07-19 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-19 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-07-19 | BTIG | Buy | Buy | Maintains |
| 2024-07-19 | Truist Securities | Buy | Buy | Maintains |
| 2024-07-19 | Stifel | Buy | Buy | Maintains |
| 2024-07-19 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-07-19 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-07-19 | Baird | Outperform | Outperform | Maintains |
| 2025-04-23 | Baird | Outperform | Outperform | Maintains |
| 2024-08-28 | BTIG | Buy | Buy | Maintains |
| 2025-01-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-01-24 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2025-01-24 | Raymond James | Outperform | Outperform | Maintains |
| 2025-01-24 | Truist Securities | Buy | Buy | Maintains |
| 2025-01-24 | Citigroup | Buy | Buy | Maintains |
| 2025-01-24 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-12-18 | Truist Securities | Buy | Buy | Maintains |
| 2024-11-26 | BTIG | Buy | Buy | Maintains |
| 2024-10-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-10-18 | Baird | Outperform | Outperform | Maintains |
| 2024-08-22 | Citigroup | Buy | Buy | Maintains |
| 2024-07-23 | Barclays | Overweight | Overweight | Maintains |
| 2024-12-02 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2024-12-05 | Stifel | Buy | Buy | Maintains |
| 2025-03-18 | Baird | Outperform | Outperform | Maintains |
| 2024-10-18 | BTIG | Buy | Buy | Maintains |
| 2024-10-18 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-10-18 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2024-10-18 | Stifel | Buy | Buy | Maintains |
| 2024-10-18 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-10-18 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-04-24 | Barclays | Overweight | Overweight | Maintains |
| 2025-03-17 | Truist Securities | Buy | Buy | Maintains |
| 2024-10-14 | BTIG | Buy | Buy | Maintains |
| 2024-10-14 | Raymond James | Outperform | Outperform | Maintains |
| 2024-10-14 | Truist Securities | Buy | Buy | Maintains |
| 2024-11-19 | Erste Group | Hold | Buy | Upgrade |
| 2024-10-01 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2024-12-11 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-12-11 | Citigroup | Buy | Buy | Maintains |
| 2025-08-19 | RBC Capital | Outperform | Outperform | Reiterate |
| 2025-05-22 | Citigroup | Buy | Buy | Maintains |
| 2025-06-09 | Deutsche Bank | Hold | Sell | Downgrade |
| 2025-07-08 | Evercore ISI Group | In-Line | In-Line | Maintains |
| 2025-07-23 | BTIG | Buy | Buy | Maintains |
